Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) was up 21.7% during trading on Thursday . The company traded as high as $0.3306 and last traded at $0.3306. Approximately 171 shares traded hands during trading, a decline of 82% from the average daily volume of 974 shares. The stock had previously closed at $0.2717.
Zelira Therapeutics Price Performance
The firm’s 50 day moving average is $0.39 and its 200-day moving average is $0.29.
Zelira Therapeutics Company Profile
Zelira Therapeutics Ltd is a clinical-stage biotechnology company focused on the development and commercialization of proprietary cannabinoid-based therapies. The company leverages a portfolio of clinical and preclinical drug candidates designed to address unmet medical needs in areas such as chronic pain, autism spectrum disorder, Alzheimer’s disease and sleep disorders. Utilizing patented formulation and delivery platforms, Zelira aims to optimize efficacy and safety profiles of plant-derived cannabinoids.
The company pursues a dual geography strategy through its Australian and North American operations.
Further Reading
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
